Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Meet The Expert

Alirucomab: Focus on high CV risk patients and mortality outcomes in Odyssey outcome

How to prevent the Event in People with T2D and ASCVD


Staying on track: Optimising the lipid-lowering pathway whilst avoiding treatment limbo

Back to top
Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V8/APR2024

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement
Back to top

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V8/APR2024